No retraction, correction or concern found when last checked on Oct 18, 2026.
Characterizing microglia activation: a spatial statistics approach to maximize information extraction
Benjamin M. Davis, Manual Salinas-Navarro, M. Francesca Cordeiro and 2 more
Scientific Reports · 2017 · CC BY
doi:10.1038/s41598-017-01747-8
Abstract
Microglia play an important role in the pathology of CNS disorders, however, there remains significant uncertainty about the neuroprotective/degenerative role of these cells due to a lack of techniques to adequately assess their complex behaviour in response to injury. Advancing microscopy techniques, transgenic lines and well-characterized molecular markers, have made histological assessment of microglia populations more accessible. However, there is a distinct lack of tools to adequately extract information from these images to fully characterise microglia behaviour. This, combined with growing economic pressures and the ethical need to minimise the use of laboratory animals, led us to develop tools to maximise the amount of information obtained. This study describes a novel approach, combining image analysis with spatial statistical techniques. In addition to monitoring morphological parameters and global changes in microglia density, nearest neighbour distance, and regularity index, we used cluster analyses based on changes in soma size and roundness to yield novel insights into the behaviour of different microglia phenotypes in a murine optic nerve injury model. These methods should be considered a generic tool to quantitatively assess microglia activation, to profile phenotypic changes into microglia subpopulations, and to map spatial distributions in virtually every CNS region and disease state.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Whilst small in size, microglia are of enormous importance for CNS health and repair. Fulfilling their neuroinflammatory role, these so-called ‘resident macrophages’ continuously probe the CNS environment for signs of distress, and migrate to sites of injury/infection/neurodegeneration where they recruit and activate additional cells, proliferate, phagocytose, clear debris and reorganize the CNS parenchyma. This microglial reactivity is a complex multistage activation process, which broadly encompasses their transformation from a ramified to an amoeboid morphology by first retracting the microglia processes and then extending dynamic protrusions, followed by cellular locomotion. Microglia dynamics are, however, sometimes very subtle, and go beyond their immune surveillance function. Indeed, microglia are believed to represent an important nexus between neurological and immunological activity in the CNS, and, for example, are also essential for synaptic homeostasis and regulation of neurotransmitters–.
Despite their central role in mounting a rapid, protective response against perturbations of CNS homeostasis, microglial activity has also been linked to various pathological conditions including neurodegenerative diseases. Indeed, while microglial reactivity may at first aid to the elimination of the source of distress and to the restoration of tissue homeostasis, persistent inflammatory stimuli (as present in e.g. Alzheimer’s, Parkinson’s diseases, amyotrophic lateral sclerosis) may ultimately overwhelm microglia and lead to a downward spiral of chronic inflammation that compromises neuronal survival,. Altogether, in response to their ever-changing surroundings, microglia display a remarkable degree of phenotypic plasticity – both in terms of morphology, number and molecular markers – and may be skewed to either a neurotoxic or a neuroprotective role. Much remains to be investigated, however, in order to understand this dynamic process and to correlate microglia phenotypes and function.
Historically, microglia phenotypes have been described by categorizing cells based on their morphological features. In general, highly ramified cells were designated ‘resting’ microglia and amoeboid cells were called ‘activated’, with a range of intermediate activation states in between (e.g., ‘intermediately activated’, ‘bipolar’, ‘rod-like’, ‘hypertrophied’, ‘bushy’). No morphological classification standard exists, however, which complicates comparison of data from different studies, and prevents objective quantification of pathological status and therapeutic effects. Nevertheless, it is well-known that microglia morphological features and function are tightly coupled,, and the development of unbiased and quantitative methods could therefore lead to improved insights into this form-function paradigm. Furthermore, microglia reactivity is a highly dynamic process, which is likely to be better described by a continuum of quantitative physiological measures – able to detect subtle changes in cell morphology and to capture the dynamics of microglia plasticity – rather than by a qualitative categorization,. Over the last years, novel methodological approaches for adequate description of the reactive transformation of microglia have been emerging (e.g., refs, –), yet correlating microglia morphology to function remains difficult and few easy-accessible user-friendly tools are presently available to adequately quantify morphological changes. In addition, microglia phenotypes appear to heterogeneous, both amongst CNS regions and within a single tissue, which emphasizes the need for comprehensive analysis of the entire microglia population.
In the current study, microglial reactivity was evaluated on whole-mounted mouse retinas, harvested four days after ONC. The ONC model has been extensively used to study retinal neurodegeneration, and the timing and pathological mechanisms leading to retinal ganglion cell death have been the subject of many studies, e.g. refs –. Furthermore, a growing interest in the detailed course of microglial reactivity in this experimental glaucoma model has been emerging–. Aiming to address this recent focus, we designed an automated analysis algorithm that, based on Iba-1 (ionized calcium-binding adapter molecule 1) immunostaining of the retinal microglia, quantifies five parameters: cell density, nearest neighbour distance (NND) and regularity index, to describe microglia numbers and distribution; and cell soma size and roundness, to assess cell morphology. Together, in combination with a spatial statistics approach, this comprehensive set of measures allows us to extract greater information from whole-retinal histology than has previously been possible, to quantitatively describe the dynamic pathological state of microglia in the retina.
Quantification of microglial activation by a novel comprehensive image analysis script
Retinal microglia were visualized by means of immunohistochemical staining for Iba-1, a commonly used macrophage/microglia-specific calcium binding protein and well-suited marker for morphological differentiation of ramified versus amoeboid microglia. Automated detection and counting of Iba-1 immunopositive cells was validated by comparison to manual counts by three masked observers. Algorithm results correlated strongly with mean manual observations and subsequent Bland-Altman analysis revealed comparable inter-operator variability between manual observers and the algorithm described herein (Fig. 1, Table 1).
Analysis of cell number and distribution to measure microglial reactivity
The first set of parameters that was analysed in our data set comprised cell density, NND and regularity index, and aimed to assess microglia numbers and distribution. First, upon comparison of microglia cell numbers in retinas of naive mice versus retinas that underwent ONC (4 days post injury), overall cell density was found to dramatically increase by 43% (185 ± 5 cells/mm2 versus 264 ± 9 cells/mm2, respectively; P < 0.005) (Fig. 2a). This was also reflected in the NND, which decreased in the ONC retinas (40.8 ± 1.0 μm versus 34.2 ± 0.7 μm; P < 0.005) (Fig. 2b). A detailed analysis of microglia density and NND in function of the distance from the ONH, furthermore revealed that microglia density tends to be higher in the central retina for all treatment groups (Fig. 2c,d). In addition, the left-shift in the cumulative density graphs (Fig. 2c, arrow) and the larger NND at increasing distance from the ONH (Fig. 2d, arrows), are suggestive of a microglia redistribution from the periphery to the centre in response to the ONC injury. Notably, this microglial response appeared to be almost identical in ONC and contralateral eyes at 4 days post ONC, and – given that the overall microglia density did not change in the contralateral eyes – proposes that at least part of the increased central cell density in the ONC retinas is the result of relocating resident microglia. These spatial organizations are illustrated by the pseudocolour maps, giving a graphical representation of microglia NND (Fig. 2e).
Second, the regularity index, which is defined as the ratio of the mean NND over the NND standard deviation and describes the regular spacing of cells, was seen to increase upon ONC (2.52 ± 0.03 versus 2.74 ± 0.04; P < 0.01) (Fig. 2e). Indeed, looking at the probability function of the NND, one can see that the mean NND shifts to the left (i.e., becomes smaller) and the distribution becomes more narrow (i.e., the standard deviation decreases) upon ONC (Fig. 2f). In other words, the NND in a population of activated microglia becomes smaller and more homogenous as the cells are more densely packed and their exclusion radii touch. The latter will be further explored in the following sections with Ripley’s K-statistics.
Intriguingly, analysis of microglia density, NND and regularity index in the contralateral eye of animals that underwent ONC, revealed that values tended to deviate from the naive eye. Although these differences were small and found not to be significant in this study, they are suggestive of a mild microglial activation in the contralateral eye in response to ONC (Fig. 2a–e).
Analysis of cell shape to measure microglial reactivity
A more detailed analysis focusing on the microglia cell somata, revealed two additional parameters that were significantly affected upon ONC. First, compared to naive mice, average cell body size increased (53.1 ± 1.3 μm2 versus 74.3 ± 2.7 μm2; P < 0.005) (Fig. 3a). Second, microglial reactivity at 4 days post ONC was also characterized by a reduction in the roundness of the cell body (0.181 ± 0.006 versus 0.160 ± 0.006 in naive and ONC retinas, respectively; P < 0.05) (Fig. 3b). Distribution analyses furthermore revealed a wider, slightly right-shifted distribution for soma size and left-shifted distribution for roundness (Fig. 3c,d). Together, these data suggest that the number of microglia with a small, round cell body decreased after ONC and that these cells adopted a bigger, more irregular soma shape. This fits the general classification of microglia morphology, which describes the surveying ‘resting’ cells as small, round cells with elaborate ramifications, and the ‘activated’ microglia as bigger, more amoeboid cells with retracted processes. Of note, no signs of activation were found when analysing cell soma size and roundness in the retina of the contralateral eye of the ONC animals (Fig. 3a–d).
K-means clustering to gain a deeper insight into microglia subpopulations with different activation states
While the above measures provide an average value for microglia soma size and roundness for each retina, they fail to take into account the heterogeneity of microglia phenotypes within a single retina. Therefore, in order to define subpopulations of microglia with a ‘low’ versus ‘high’ activation status, we performed K-means clustering that divided the data into two main categories based on microglia soma size and roundness (Fig. 4a). We defined these clusters as ‘low activity’ and ‘high activity’ microglia, rather than ‘resting’ versus ‘activated’ cells, as we believe that this traditional classification fails to capture the diverse functions of microglia in both healthy and diseased CNS tissues. Microglia falling in the first category had small yet round somata and therefore resemble the typical morphological features of so-called resting microglia; microglia in the ‘high activity’ cluster displayed typical signs of microglial reactivity, i.e., an increased soma size and more irregular shape of their cell body, and thereby come close to the amoeboid-like morphology that is typically associated with activated microglia. This K-means clustering revealed that in a naive retina on average 65 ± 1% of the microglia fell into the ‘low activity’ and 35 ± 1% in the ‘high activity’ cluster (120 ± 3 versus 65 ± 4 cells/mm2, respectively). While the number of ‘low activity’ cells remained the same (126 ± 6 cells/mm2), the number of ‘high activity’ microglia doubled to 139 ± 8 cells/mm2 (P < 0.005) in the ONC eyes, resulting in a ratio of 49 ± 2% ‘low activity’ versus 51 ± 2% ‘high activity’ microglia (Fig. 4c,d). In the contralateral eye, no significant differences were seen, although the population of ‘low activity’ microglia tended to somewhat increase in comparison to naive retinas (from 65 ± 1% to 70 ± 1%) (Fig. 4c,d). Finally, graphical representations of the distribution of ‘low activity’ and ‘high activity’ microglia hint that there were no regional differences in microglia activation (Fig. 4c).
Ripley’s K-statistics and Dixon’s χ2-test to resolve microglia territories and spatial dynamics
In a spatial statistics analysis, using L(r) and H(r) derivatives of Ripley’s K-function, we investigated the topographical organization of retinal microglia. The negative values found for L(r) and H(r) indicate that microglia tend to disperse rather than cluster together in foci (Fig. 5a,b). Calculating the second minimum of the derivative of H(r) yielded the average size of the microglia territories under the different experimental conditions (Fig. 5b). In naive and ONC eyes, the average microglia domain radius was 58.6 ± 1.4 μm and 44.9 ± 0.6 μm, respectively, indicating that microglia activation coincides with a reduction in size of the microglia territories (P < 0.005) (Fig. 5c). Notably, in the contralateral eyes, microglia also somewhat decreased their domain radius (54.6 ± 1.5 μm), yet this effect was not significant. Running cross-K (K ij) and self-K functions (K ii and K jj) (where i stands for ‘low activity’ microglia and j for ‘high activity’ microglia) furthermore revealed that, in response to ONC, both ‘low activity’ and ‘high activity’ microglia reduce their domain radii to a similar extent (Fig. 5d). Domain radii are thus modulated independent of activation status.
Finally, Dixon’s χ2-test for testing spatial segregation was applied, focusing on the identity (i.e., ‘low activity’ or ‘high activity’) of the nearest neighbour of each microglia rather than the distance between them. A Dixon’s χ2-test was applied to the distribution of ‘low activity’ or ‘high activity’ microglia versus simulated random distributions, to examine whether microglia had a tendency to cluster beyond the exclusion radii identified above. A summary of the number of ‘low activity’ and ‘high activity’ microglia and the χ2-statistics, degrees of freedom, and p-values is provided in Table 2. The complete results are available as a Supplementary Table. Investigation of these test statistics revealed that microglia from both subpopulations have a mild tendency towards self-association. Upon ONC, however, a large increase in ‘high activity’ microglia clustering was observed. Indeed, across the 14 naive retinas included in this analysis, the aggregate C = 47.81 with 28 degrees of freedom yielded a p-value of 0.0112. Dixon’s χ2-test thus points to a tendency for ‘low activity’ and ‘high activity’ microglia to spatially segregate differently that what is expected under random labelling. The p-values of squared-summed z ii = 25.00 (P = 0.0346) and z jj = 26.55 (P = 0.0220) with 14 degrees of freedom indicated that both microglia subtypes tend to self-associate. At four days post ONC, the aggregate C = 143.57 with 28 degrees of freedom had a p-value < 0.000001, indicative of a very strong deviation from random labelling and from the naive condition. The square-summed z ii = 23.72 with 14 degrees of freedom and p-value = 0.0495 corresponded to our observations in the naive retina, suggesting that ‘low activity’ microglia did not behave differently in naive versus ONC retinas. In contrast, the squared summed z jj = 104.80 with 14 degrees of freedom and P < 000001 proposes that a large increase in ‘high activity’ microglia clustering is responsible for the increase in aggregate C versus naive retina. Spatial segregation of retinal microglia in the contralateral eye was similar to the naive retina. In summary, ‘high activity’ microglia preferentially self-associate, which could be explained by their cytokine-mediated cross-talk leading to activation of neighbouring cells and/or recruitment of additional microglia/macrophages.
Discussion
Given that changes in microglia activation can be elucidated from changes in population size and morphology, independent of any molecular markers of activation, quantitative analysis these parameters can be used to assess the pathologic state of a given tissue. In this study, we exemplified this approach by describing microglia activation in a mouse ONC model, based on a five-parameter morphological analysis. Initially, we performed a global analysis of these activity markers in the entire retina and calculated average values, using traditional parametric statistical methods. Next, non-parametric cluster analysis and spatial segregation statistics were applied to this data set, in order to investigate the heterogeneity of microglia subpopulations and their spatial organization within the retina.
A comprehensive view on retinal microglia activation following optic nerve injury
Together, the results from this study can be integrated in order to model how microglia number, distribution, and morphology change in relation to microglia activation (Fig. 6). This shows that, at four days post ONC, microglial activation in the retina leads to, first, microglia proliferation/macrophage infiltration, which is visible as an increase in the density of Iba-1+ cells; and, second, to a more closely packed yet regularly spaced organization, as evidenced by the measures of nearest neighbour distance and regularity index. More in-depth analysis of microglia topographic organization via Ripley’s K-statistics confirms that their exclusion radius reduces upon ONC. This plasticity of microglia territories appears to be conserved in all treatment groups, suggesting that this may constitute an intrinsic cell-cell interaction mechanism that ensures efficient microglia surveillance covering the entire retina. As the radii of these territories were found to be similar for ‘low activity’ and ‘high activity’ microglia, this phenomenon appears to be independent from microglia size/morphology (i.e., the territory covered by microglia processes), but may instead be the result of chemotactic signalling. In addition, microglia activation is associated with an increase in cell body size and a decrease in its roundness, reflecting the morphological transition from a ramified ‘resting’ to an activated amoeboid-like phenotype. Based on these two measures, we performed a K-means clustering to segment microglia populations into two subtypes, i.e., ‘high activity’ and ‘low activity’ microglia. Although this clustering is somewhat artificial, by categorizing microglia into either of the two limits of their spectra of phenotypes, it can be used to gain more insight into the diverging behaviour of ‘high activity’ and ‘low activity’ microglia, provided that the limitations of this approach are considered. Indeed, re-evaluation of microglia density for each of the clusters pointed out that the increase in microglia density after ONC is merely an increase in the number of ‘high activity’ microglia. Finally, Dixon’s χ2 spatial statistics disclosed that these ‘high activity’ microglia are more often surrounded by other ‘high activity’ microglia, which might be a reflection of their cell-cell communication that is designed to mount a self-propagating inflammatory response (Fig. 6).
Overall, these findings agree with other studies of microglial activity in mouse ONC models of glaucomatous retinal neurodegeneration, which revealed proliferation of microglia taking place within the first week post ONC, as well as shape simplification and enlargement of their soma size,. Despite following a different time course, identical changes in microglia appearance are also seen in other experimental rodent glaucoma models–,, –. Notably, although not statistically significant, our findings hinted towards a low-grade immune response in the contralateral eyes, thereby corroborating previous findings in rodent glaucoma models–.
Microscopic spatial statistics: a novel, generic approach to study microglia dynamics
The major strength of our approach, wherein its innovation lies in comparison to the traditional morphological categorization of microglia, is that it allows for the detection of changes in cell morphology in a very large number of cells. Indeed, rather than focusing on a detailed, manual/qualitative/semi-quantitative analysis of a limited number of cells in a small region of interest, we performed a population analysis including all microglia in the retina. As such, and by focusing on cell soma shape and size rather than on skeleton analysis, we choose high-throughput and moderate computing over detailed, single-cell analysis and avoid the need for high-resolution, high-magnification images. This overall approach is in contrast to fractal and Sholl analyses, the two most commonly used alternative analysis methods,,,. Our results prove that this strategy allows to gain advanced insights into microglia activation dynamics, especially by combining conventional statistics on population averages with clustering analyses of these large data sets. Because of the very large sample sizes, combined with K-means, Ripley’s K-statistics and Dixon’s χ2 spatial statistics, our method is able to capture the heterogeneous morphological transformations that go with microglia activation dynamics and may – in a future approach – aid to link the continuum of these morphological subpopulations to physiological differences. Indeed, as was also recently suggested by Verdonck et al. – who used a similar K-means approach to analyse microgliosis in the brain following endotoxemia – expanding the number of parameters in the clustering analysis (e.g., additional morphological features, gene expression signatures,…) could refine the classification of microglia subtypes and lead to a better understanding of morphology-function relations. Furthermore, microscopic spatial statistical approaches can be used to shed light on how the spatiotemporal distribution of microglia subtypes changes during disease progression by interacting with themselves and other cell types.
To conclude, the spatial statistics approach described herein addresses some of the current needs of modern biological research, by providing a means to fully explore the quantity and complexity of information contained in microscopic images,. Our method is efficient, objective, and sensitive, and helps to reveal subtleties in microglia behaviour that are otherwise undetectable to the human eye. Importantly, the workflow described here comes with very few prerequisites and can therefore be considered a generic approach applicable to the entire CNS. Virtually any tissue of any species in any pathophysiological state can be assessed, as long as microglia are labelled with a sufficient signal-to-noise ratio. The current approach may thus also be applied to tissues stained with alternative microglia/macrophage markers (e.g. CD11b, isolection B4, F4/80) or with transgenically labelled cells in reporter lines (e.g. CX3CR1-GFP mice, Tg(coro1a:eGFP; lyz:Dsred) zebrafish),,, and aid to the maximization of information extracted from any study looking into microglia activation. As such, besides dramatically improving the quality of the data, with this microscopic spatial statistics approach we also react to the increasing scrutiny of the scientific, ethical and economic use of procedures involving animals.
Animals
All studies were conducted in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the European Communities Council Directive of 22 September 2010 (2010/63/EU) and the Belgian legislation (KB of 29 May 2013), and were approved by the KU Leuven institutional ethical committee (P025-2013). Wild type mice (C57Bl6/J; Charles River Laboratories), aged 2 to 4 months, were kept under a 12/12 h light-dark cycle and had ad libitum access to food and water.
Surgical procedures
Intraorbital optic nerve crush (ONC) was performed as described in 14 animals. Briefly, a temporal incision was made in the conjunctiva and the exposed optic nerve was then crushed 1 mm from the globe with a cross-action forceps (no. 11262-30, Fine Science Tools) for 5 seconds. Funduscopy was performed before and after the procedure to assess integrity of retinal perfusion. Animals were sacrificed at 4 days post ONC.
All surgical procedures were performed under general anaesthesia with xylazine (i.p. 10 mg/kg body weight, XYL-M) and ketamine (i.p. 70 mg/kg body weight, Nimatek). After the procedure, an antibiotic ointment (tobramycin 3 mg/g, Tobrex) was applied to avoid infection and corneal desiccation. Naive eyes from a separate cohort of untreated animals served as controls (N = 14).
Immunohistochemistry for Iba-1 on retinal whole-mounts
In order to label microglia (and potential macrophages infiltration from the circulation), an Iba-1 immunostaining was performed on retinal whole-mounts. Mice were deeply anaesthetized (i.p. 30 mg/kg sodium pentobarbital, Nembutal) and sacrificed by cervical dislocation. Eyes were dissected and fixed for 1 hour in 4% PFA. Next, retinas were whole-mounted and again fixed for 1 hour in 4% PFA. Whole-mounted retinas were frozen for 15 minutes at −80 °C and rabbit anti-Iba-1 (Wako Chemicals, #019-19741) (1:1000), diluted in 10 mM phosphate-buffered saline (PBS) containing 2% Triton X-100 and 2% goat pre-immune serum, was applied overnight. The next day, a secondary goat anti-rabbit IgG antibody conjugated to an Alexa fluorophore-488 (Life Technologies) (1:200) was applied for 2 hours. Retinal whole-mounts were rinsed with PBS with 0.5% Triton X-100 in between steps, and mounted using mowiol mounting medium (10% mowiol 4–88, 40% glycerol, 0.1% 1,4-diazabicyclo-[2,2,2]-octane in 0.2 M Tris-HCl [pH 8.5]). Mosaic z-stack images (step size 3 μm; 20–30 stacks per image, comprising the retinal nerve fibre layer till the photoreceptor layer; 20x objective; 1 pixel = 1.24 μm) of the entire whole-mount were taken with a laser confocal scanning microscope (FV1000, Olympus), controlled with FluoViewer 4.2 software (Olympus), and a maximum intensity projection was made for further analysis.
Automatic quantification of Iba-1 labelled microglia in retinal whole-mounts
(Step 1) Image analysis was performed using Fiji (ImageJ, v1.51 h, 64 bit Windows) software with MorphoLibJ (v1.3.1) integrated library and plugin. Quantification of Iba-1 labelled microglia in retinal whole-mounts was achieved using a multi-step algorithm. First, segmentation of Iba-1 labelled microglia was achieved by applying a grey scale attribute opening filter (area minimum: 25 pixels; connectivity: 8) to an 8-bit maximum projection of the retinal whole-mount. An opening morphological filter (1-pixel radius octagon) was then used effectively to separate microglia soma from processes, before a maximum entropy threshold was used to segment microglia soma from image background.
(Step 2) Quantification of microglia soma was completed using the Fiji (ImageJ) Analyse Particles function with a particle size threshold of 10 pixels, to exclude small pixel noise and extract information regarding microglial soma area, centre of mass and roundness (equation 1).where A is the area of the microglia soma and M is the length of the major axis, derived from the longest axis of an ellipse fit to each microglia soma. In order to plot the above measures as a function of the distance from the ONH, the Euclidean distance of each microglia centroid, relative to the centre of the optic nerve head (ONH), was determined using a technique previously described for retinal ganglion cells (equation 2).where d is the microglia Euclidian distance, (a, b) is the coordinate centre of the ONH (determined manually) and (x, y) is the centroid of each microglia within a retina. Results were presented as percentage frequency distributions (bin size: 50 µm) to allow averaging of multiple retinas and comparisons between treatment groups.
(Step 3) Nearest neighbour distance (NND) was determined using a script for Fiji (ImageJ) developed by Y. Mao and only particles with a NND < 14 pixels were considered to be microglia, in order to exclude large process artefacts from subsequent analysis. Regularity index (RI) was calculated using equation 3:where XNND is the average NND of a population and δNND is the standard deviation of that population.
(Step 4) Whole-mount retinal area was determined as described previously. Briefly, a low intensity threshold (0–5) was applied to each 8-bit image by operators masked to treatment groups. The pixel area of this selection was measured using Fiji (ImageJ) and converted to mm2, and from this selection the global microglia density was determined by dividing the total microglia population by total retinal area. The boundary of each retinal area were exported as a list of xy-coordinates and used in conjunction with microglia centroid coordinates to generate spatial point processes with retinal area boundaries.
A detailed description of the microglia segmentation process, as well as a link to the Fiji source code, is included as a supplementary file. The Fiji source code is also publicly available via http://bio.kuleuven.be/df/lm/research/methods. The data sets generated and analysed during the current study are available from the corresponding author on reasonable request.
Parametric statistical analyses
For parametric statistics, normal distribution and parallel equal variance between groups was tested via D’Agostino-Pearson (omnibus K2) and Brown-Forsythe tests, respectively. A significance level of α < 0.05 was considered significant (*P < 0.05, **P < 0.01, ***P < 0.005). All data are described as mean ± SEM in the text. GraphPad Prism 5 (GraphPad Software) was used for all analyses, including Bland-Altman plots.
K-means clustering and colour mapping
Soma area and roundness data for each microglia identified in this study were pooled before normalization with 90% winsorizing of each population to remove extreme values. K-means clustering, using the protocol described by Hartigan and Wong, was determined using the K-means function in the R stats software package (v3.3.1), with two centres corresponding to ‘low’ and ‘high’ activity microglia populations. After ascribing clusters, microglia populations were separated by retina, and colour maps of microglia centroids (x, y coordinates) plotted with ‘low’ activity microglia were identified as black and ‘high’ activity microglia in red.
Ripley’s K- and L-functions
Microglia centroids from each retina were used in conjunction with ‘low’ or ‘high’ activity designations to create spatial point processes bounded by retinal area. To determine the extent of microglia distribution deviation from spatial homogeneity, Ripley’s K-functions were applied using the Kest function from the R spatstat software package, to compare microglia spatial point patterns and assess deviation from compete spatial randomness. Initially, K-functions for unmarked spatial point processes (equation 4) were drawn as previously described.where N is the number of cells within distance r of another point, λ is the average cell density per unit area and P i is the ith cell and the sum taken over n cells.
Compete spatial randomness was estimated using a random Poisson distribution K(r) = πr 2 where r > 0. Deviations from this estimation are indicative of incidence of clustering or dispersion. To facilitate data analysis, the variance stabilized Ripley’s K-function L(r) was calculated using the protocol proposed by Besag (equation 5).
Using this transformation, under compete spatial randomness, r is linear and L(r) > r is indicative of clustering and L(r) < r is indicative of dispersal. L(r) can be further normalized to produce the H-function, such that the expected value of r under compete spatial randomness is zero (equation 6).
This transformation is useful for the analysis of microglia spatial point processes. Using an adaptation of the work of Kiskowski et al., the radii of microglia territories (exclusion radii) can be estimated as the second minima – as microglia distribution is a dispersal rather than clustering process – of H(r), excluding the first minima that are an artefact of the algorithms NND exclusion radii. To determine whether the exclusion radii of ‘low activity’ (Kii), ‘high activity’ (Kjj) and intergroup (Kij) microglia populations changed upon ONC injury, changes in the spatial behaviour of ‘high’ and ‘low activity’ microglia populations across marked point processes were assessed, using the self-K and cross-K functions of the R spatstat software package for each retina.
Dixon’s χ2-test
As microglia population clustering could occur independent of the existence of exclusion radii previously identified, a Dixon χ2-test was employed to evaluate spatial segregation of ‘low activity’ and ‘high activity’ microglia. Using the dixon software package in R, nearest neighbour contingency tables were constructed for microglia populations for each retina and results summed across multiple retina (Naive, ONC and Co-eye treatment groups) to produce a process-wide test statistics. Deviation from random distribution of microglia populations was assessed using an overall test of segregation between (C) and within (z ii and z jj) groups, compared to results expected under random labelling, according to the methods described by Dixon et al..
References 52
- 1.
Nayak D, Roth TL, McGavern DB. Microglia Development and Function. Annl Rev Immunol. 2014;32:367-402.
Not in our library10.1146/annurev-immunol-032713-120240
- 2.
Wake H, Moorhouse AJ, Nabekura J. Functions of microglia in the central nervous system–beyond the immune response. Neuron glia biol. 2011;7:47-53.
Not in our library10.1017/s1740925x12000063
- 3.
- 4.
Tang Y, Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2015.
Not in our library10.1007/s12035-014-9070-5
- 5.
- 6.
- 7.
Streit WJ. Microglial Response to Brain Injury: A Brief Synopsis. Toxicol Pathol. 2000;28:28-30.
Not in our library10.1177/019262330002800104
- 8.
- 9.
Megjhani M, et al. Population-scale three-dimensional reconstruction and quantitative profiling of microglia arbors. Bioinformatics. 2015;31:2190-2198.
Not in our library10.1093/bioinformatics/btv109
- 10.
- 11.
Hovens IB, Nyakas C, Schoemakers RG. A novel method for evaluating microglial activation using ionized calcium-binding adaptor protein-1 staining: cell body to cell size ratio. Neuroimmunol Neuroinflamm. 2014;1:82-88.
Not in our library10.4103/2347-8659.139719
- 12.
Verdonk F, et al. Phenotypic clustering: a novel method for microglial morphology analysis. J Neuroinflammation. 2016;13:153.
Not in our library10.1186/s12974-016-0614-7
- 13.
Agudo M, et al. Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush. Mol Vis. 2008;14:1050-1063.
Not in our library
- 14.
Tezel G, Yang X, Yang J, Wax MB. Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res. 2004;996:202-212.
Not in our library10.1016/j.brainres.2003.10.029
- 15.
De Groef L, et al. Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains. Exp Eye Res. 2016;145:235-247.
Not in our library10.1016/j.exer.2016.01.006
- 16.
Sanchez-Migallon MC, Valiente-Soriano FJ, Nadal-Nicolas FM, Vidal-Sanz M, Agudo-Barriuso M. Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor. Invest Ophthalmol Vis Sci. 2016;57:81-93.
Not in our library10.1167/iovs.15-17841
- 17.
Bosco A, Romero CO, Ambati BK, Vetter ML. In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma. J Vis Exp. 2015;11:52731.
Not in our library10.3791/52731
- 18.
Ebneter A, Casson RJ, Wood JPM, Chidlow G. Microglial Activation in the Visual Pathway in Experimental Glaucoma: Spatiotemporal Characterization and Correlation with Axonal Injury. Invest Ophthalmol Vis Sci. 2010;51:6448-6460.
Not in our library10.1167/iovs.10-5284
- 19.
Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519:599-620.
Not in our library10.1002/cne.22516
- 20.
Mac Nair CE, Schlamp CL, Montgomery AD, Shestopalov VI, Nickells RW. Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways. J Neuroinflammation. 2016;13:93.
Not in our library10.1186/s12974-016-0558-y
- 21.
Wohl SG, Schmeer CW, Witte OW, Isenmann S. Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion. Invest Ophthalmol Vis Sci. 2010;51:2686-2696.
Not in our library10.1167/iovs.09-4537
- 22.
Das Sarma S, Chatterjee K, Dinda H, Chatterjee D, Das Sarma J. Cytomorphological and Cytochemical Identification of Microglia. ISRN Immunology. 2013;2013:10.
Not in our library10.1155/2013/205431
- 23.
Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
Not in our library10.1177/096228029900800204
- 24.
McLarnon JG. Microglial chemotactic signaling factors in Alzheimer’s disease. Am J Neurodegener Dis. 2012;1:199-204.
Not in our library
- 25.
Galindo-Romero C, et al. Effect of Brain-Derived Neurotrophic Factor on Mouse Axotomized Retinal Ganglion Cells and Phagocytic Microglia. Invest Ophthalmol Vis Sci. 2013;54:974-985.
Not in our library10.1167/iovs.12-11207
- 26.
Trost A, et al. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension. Exp Eye Res. 2015;136:59-71.
Not in our library10.1016/j.exer.2015.05.010
- 27.
Chiu K, Yeung S-C, So K-F, Chang RC-C. Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol Immunol. 2010;7:61-68.
Not in our library10.1038/cmi.2009.110
- 28.
de Hoz R, et al. Rod-Like Microglia Are Restricted to Eyes with Laser-Induced Ocular Hypertension but Absent from the Microglial Changes in the Contralateral Untreated Eye. PLoS One. 2013;8:e83733.
Not in our library10.1371/journal.pone.0083733
- 29.
de Gracia P, et al. Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas. PLoS One. 2015;10:e0143278.
Not in our library10.1371/journal.pone.0143278
- 30.
- 31.
- 32.
Bodeutsch N, Siebert H, Dermon C, Thanos S. Unilateral injury to the adult rat optic nerve causes multiple cellular responses in the contralateral site. J Neurobiol. 1999;38:116-128.
Not in our library10.1002/(sici)1097-4695(199901)38:1<116::aid-neu9>3.0.co;2-f
- 33.
Soltys Z, et al. Quantitative morphological study of microglial cells in the ischemic rat brain using principal component analysis. J Neurosci Methods. 2005;146:50-60.
Not in our library10.1016/j.jneumeth.2005.01.009
- 34.
Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K. Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res. 2001;63:90-97.
Not in our library10.1002/1097-4547(20010101)63:1<90::aid-jnr11>3.0.co;2-9
- 35.
Meijering E, Carpenter AE, Peng H, Hamprecht FA, Olivo-Marin J-C. Imagining the future of bioimage analysis. Nat Biotech. 2016;34:1250-1255.
Not in our library10.1038/nbt.3722
- 36.
Davis BM, et al. Towards maximising information extraction from rodent models of ocular disease. Cell Death Dis. 2016;7:e2270.
Not in our library10.1038/cddis.2016.174
- 37.
Li L, Yan B, Shi Y-Q, Zhang W-Q, Wen Z-L. Live Imaging Reveals Differing Roles of Macrophages and Neutrophils during Zebrafish Tail Fin Regeneration. J Biol Chem. 2012;287:25353-25360.
Not in our library10.1074/jbc.m112.349126
- 38.
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Meth9, 676–682, http://www.nature.com/nmeth/journal/v9/n7/abs/nmeth.2019.html (2012).
Not in our library10.1038/nmeth.2019
- 39.
Legland D, Arganda-Carreras I, Andrey P. MorphoLibJ: integrated library and plugins for mathematical morphology with Image. J. Bioinformatics. 2016;32:3532-3534.
Not in our library10.1093/bioinformatics/btw413
- 40.
Davis BM, et al. Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies. Cell Death Discov. 2016;2:16031.
Not in our library10.1038/cddiscovery.2016.31
Cited by papers we hold 2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.